COLLEGIUM PHARMACEUTICAL, INC Logo

COLLEGIUM PHARMACEUTICAL, INC

Develops and commercializes abuse-deterrent medications for responsible chronic pain management.

COLL | US

Overview

Corporate Details

ISIN(s):
US19459J1043
LEI:
Country:
United States of America
Address:
100 TECHNOLOGY CENTER DRIVE, 2072 STOUGHTON
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Collegium Pharmaceutical, Inc. is a specialty biopharmaceutical company dedicated to developing and commercializing medications for people with serious medical conditions. The company's primary focus is on pain management, offering a portfolio of differentiated products designed to treat chronic pain responsibly. A key aspect of its scientific approach is the development of abuse-deterrent formulations. Collegium is engaged in the full lifecycle of its products, from development to commercialization and distribution in the United States, supporting both patients and healthcare providers.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all COLLEGIUM PHARMACEUTICAL, INC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for COLLEGIUM PHARMACEUTICAL, INC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for COLLEGIUM PHARMACEUTICAL, INC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Novo Nordisk Logo
Develops medicines and devices for chronic diseases like diabetes, obesity, and rare disorders.
Denmark NOVO
NRX Pharmaceuticals, Inc. Logo
Develops novel oral drugs for CNS disorders, targeting suicidal depression and PTSD.
United States of America NRXP
NuCana plc Logo
Develops safer anti-cancer medicines with ProTide technology to overcome cell resistance.
United States of America NCNA
NUFORMIX PLC Logo
Repurposing drugs for fibrosis and oncology using proprietary cocrystal technology.
United Kingdom NFX
Nurix Therapeutics, Inc. Logo
Developing protein degradation medicines to treat cancer and autoimmune diseases.
United States of America NRIX
NUTEX Investments Plc Logo
Develops & distributes health, cosmetic & pharma products from natural ingredients globally.
Hungary NUTEX
NutriBand Inc. Logo
Develops abuse-deterrent transdermal patches to make potent drug delivery safer.
United States of America NTRB
Nuvalent, Inc. Logo
Designs targeted small molecule drugs for kinase-driven cancers to overcome treatment resistance.
United States of America NUVL
Nuvation Bio Inc. Logo
A clinical-stage biopharma developing novel drugs for difficult-to-treat cancers.
United States of America NUVB
Nxera Pharma Co., Ltd. Logo
Biopharma using SBDD tech to develop medicines for neurology and gastroenterology.
Japan 4565

Talk to a Data Expert

Have a question? We'll get back to you promptly.